Φορτώνει......
Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
INTRODUCTION: Access to pimavanserin, the only Parkinson disease–related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiation, patients require monitoring for safety and effectiveness. The primary objec...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ment Health Clin |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
College of Psychiatric & Neurologic Pharmacists
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120983/ https://ncbi.nlm.nih.gov/pubmed/34026394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.187 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|